Evaluation of End of Life Quality of Care

Completed

• Conditions: End of Life Care; Neoplasm Malignant; Quality of Life

• Registration Number: NCT03775304
• Lead Sponsor: Assistance Publique - Hôpitaux de Paris

Brief Summary

The study uses a mixed method study to evaluate wether the use of the indicators of the Quality of end-of-life cancer care, developed by Earle et al \[Earle JCO 2003; DOI: 10.1200/JCO.2003.03.059\] would be relevant and measurable in France. The qualitative part of study was designed to investigate the representations of quality by face-to face interviews with family carer of recently deceased cancer patients, and with their oncologists, and nurses. The quantitative part of the study, consisted in a decedents case series analysis, diagnosed with advanced cancer and followed up in 5 centers. Data on trajectory of care were collected from different complementary sources associating national mortality data, hospital activity data, and health records.

The study was approved by the French data protection authority (CNIL) number 611273.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-01-01
• Primary Completion: 2015-12-15
• Study Completion: 2015-12-15
• Status Verified: 2017-03
• Study First Submitted: 2018-12-06
• Study First Submitted QC: 2018-12-12
• Last Update Submitted: 2018-12-12
• Study First Posted: 2018-12-13
• Last Update Posted: 2018-12-13

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 997

Inclusion Criteria

Not provided

Exclusion Criteria

• diagnosis with non solid tumor (haematology)
• age < 18

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Use of emergency services within last 30 days before death	Through study completion, up to 1 year

Secondary Outcome Measures

Name	Time	Method
Admission in intensive care unit within last 30 days before death	Through study completion, up to 1 year
Location of death	Through study completion, up to 1 year
Among patients with pain relief opioid treatment, those with combined short term and long acting opioid orders	Through study completion, up to 1 year
Patients received chemotherapy in the last 14 days of life	Through study completion, up to 1 year
Among patients who died in palliative care unit, those who died within 3 days after admission	Through study completion, up to 1 year

Trial Locations

Locations (5)

Institut Curie; 🇫🇷 Paris, Ile De France, France

APHP Hôpital Cochin; 🇫🇷 Paris, France

APHP Hôpital Européen Georges Pompidou; 🇫🇷 Paris, France

APHP Hôpital Henri Mondor; 🇫🇷 Paris, France

Institut Gustave Roussy; 🇫🇷 Villejuif, France